Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells

被引:218
作者
Hwang, JM
Kuo, HC
Tseng, TH
Liu, JY
Chu, CY
机构
[1] Chung Shan Med Univ, Sch Appl Chem Care & Management Coll, Taichung 402, Taiwan
[2] Chung Shan Med Univ, Med Coll, Inst Biochem & Biotechnol, Taichung 402, Taiwan
关键词
berberine; hepatoma; apoptosis;
D O I
10.1007/s00204-005-0014-8
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Berberine, a main component of Coptidis Rhizoma, is a plant alkaloid with a long history of medicinal use in Chinese medicine. Berberine has indicated significant antimicrobial activity against a variety of organisms including bacteria, viruses, fungi. The mechanism by which berberine initiates apoptosis remains poorly understood. In the present study, we demonstrated that berberine exhibited significant cytotoxicity in hepatoma HepG2 cells but is ineffective in Chang liver cells. Herein we investigated cytotoxicity mechanism of berberine in HepG2 cells. The results showed that HepG2 cells underwent internucleosomal DNA fragmentation after 24-h treatment with berberine (50 mu M). Moreover, berberine induced the activation of caspase-8 and -3, and caused the cleavage of poly ADP-ribose polymerase (PARP) and the cytochrome c release, whereas the expression of Bid and anti-apoptosis factor Bcl-XL were decreased markedly. The loss of mitochondrial membrane potential (Delta psi m) at 24 h and activation of Fas at 12 h were also seen in the berberine-treated HepG2 cells. These findings supported the fact that the inhibitors of caspases, DEVD-FMK, IETD-FMK and VAD-FMK, prevented apoptosis and restored the expression of Bcl-XL, Bcl-2 and Bid. These results indicated that the potential of anti-hepatoma activity of berberine may be mediated through a caspases-mitochondria-dependent pathway.
引用
收藏
页码:62 / 73
页数:12
相关论文
共 49 条
[1]   Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL [J].
Abou el Hassan, MAI ;
Mastenbroek, DCJ ;
Gerritsen, WR ;
Giaccone, G ;
Kruyt, FAE .
BRITISH JOURNAL OF CANCER, 2004, 91 (01) :171-177
[2]  
AKHTER MH, 1977, INDIAN J MED RES, V65, P133
[3]   BERBERINE SULFATE - ANTIMICROBIAL ACTIVITY, BIOASSAY, AND MODE OF ACTION [J].
AMIN, AH ;
SUBBAIAH, TV ;
ABBASI, KM .
CANADIAN JOURNAL OF MICROBIOLOGY, 1969, 15 (09) :1067-&
[4]  
Bahar S, 2000, J NEUROPHYSIOL, V84, P311
[5]  
BOVA S, 1992, J PHARMACOL EXP THER, V261, P318
[6]   Modulation of cell death by Bcl-xL through caspase interaction [J].
Clem, RJ ;
Cheng, EHY ;
Karp, CL ;
Kirsch, DG ;
Ueno, K ;
Takahashi, A ;
Kastan, MB ;
Griffin, DE ;
Earnshaw, WC ;
Veliuona, MA ;
Hardwick, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :554-559
[7]   The kiss of death: promises and failures of death receptors and ligands in cancer therapy [J].
Daniel, PT ;
Wieder, T ;
Sturm, I ;
Schulze-Osthoff, K .
LEUKEMIA, 2001, 15 (07) :1022-1032
[8]   Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis [J].
Desagher, S ;
Osen-Sand, A ;
Nichols, A ;
Eskes, R ;
Montessuit, S ;
Lauper, S ;
Maundrell, K ;
Antonsson, B ;
Martinou, JC .
JOURNAL OF CELL BIOLOGY, 1999, 144 (05) :891-901
[9]   Role of chemopreventive agents in cancer therapy [J].
Dorai, T ;
Aggarwal, BB .
CANCER LETTERS, 2004, 215 (02) :129-140
[10]   Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells [J].
Fukuda, K ;
Hibiya, Y ;
Mutoh, M ;
Koshiji, M ;
Akao, S ;
Fujiwara, H .
JOURNAL OF ETHNOPHARMACOLOGY, 1999, 66 (02) :227-233